Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus

The clinical trial of allogenic mesenchymal stem cells (MSCs) transplantation for refractory SLE patients has shown significant safety and efficacy profiles. However, the optimum frequency of the MSCs transplantation (MSCT) is unknown. This study was undertaken to observe whether double transplantat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dandan, Akiyama, Kentaro, Zhang, Huayong, Yamaza, Takayoshi, Li, Xia, Feng, Xuebing, Wang, Hong, Hua, Bingzhu, Liu, Bujun, Xu, Huji, Chen, Wanjun, Shi, Songtao, Sun, Lingyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399403/
https://www.ncbi.nlm.nih.gov/pubmed/22829849
http://dx.doi.org/10.1155/2012/273291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3399403/
https://www.ncbi.nlm.nih.gov/pubmed/22829849
http://dx.doi.org/10.1155/2012/273291

Ejemplares similares